October 8, 2015
Lilly Receives FDA Breakthrough Therapy Designation for Abemaciclib in Advanced Breast Cancer
Eli Lilly and Company has announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to…